Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline-N, N-dimethylamide
US9145397B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 30, 2012 |
| Grant date | Sep 29, 2015 |
| Priority date | — |
| Expiry date | Aug 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a new process for the preparation of a crystalline polymorph of a vasopressin V2 agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.